In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-14 of 14 for your search:
Cancer Type/Condition:  ductal breast carcinoma in situ
Stage/Subtype:  ductal breast carcinoma in situ
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

2.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00702, CDR0000615085, NSABP B-43, U10CA180868, U10CA012027, NCT00769379

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Approved-not yet active
Age: 25 to 55
Sponsor: NCI, Other
Protocol IDs: A211102, U10CA031946, NCI-2013-00995, NCT01905046

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143

5.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000651359, OSU-08177, 2009C0041, NCT01008514

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CALGB-40903, CDR0000701992, U10CA037447, NCI-2011-03452, NCT01439711

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: I 108907, NCI-2009-01568, P30CA016056, NCT01754519

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

10.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00875, 2008-0086, CDR0000573719, H-19895, P50-CA-58183, P50CA058183, P30CA016672, MDA-P50-CA-58183, BCM-H-19895, BCM-P50-CA-58183, NCT00555152

11.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000633754, UCD-CCSO001, 200816282-1, CCSO001, NCT00859157

12.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 090100, 09-C-0100, NCT00924027

13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-13311, NCI-2010-02342, P30CA016059, NCT01293032

14.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: ZCC-2010, U54CA142152-02, NCT01400399
New Search